Scheme

Aditya Birla Sun Life Nifty Healthcare ETF

Holds 20 companies worth ₹74.7 Cr in Sept 2026.

Fund house
Aditya BirlaThe fund house that runs this scheme.
AUM
₹74.7 CrAditya Birla Sun Life Nifty Healthcare ETF's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 10.5% on Aug 2026, ₹83.4 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 17.0% of this scheme's NAV.
Fund manager
Priya SridharRuns its co-manager part since 31 Dec 2024, as the fund house dates it. With Mehul Dama (co-manager).

Holdings^{(Oct 2021 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	20 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	12.7
	Divi s Laboratories Limited	7.8
	Apollo Hospitals Enterprise Limited	5.6
	Laurus Labs Limited	5.1
	Cipla	5
	Dr Reddy s Laboratories Limited	5
	Torrent Pharmaceuticals Limited	4.7
	Max Healthcare Institute Limited	4.6
	Lupin	3.3
	Aurobindo Pharma	3.1
	Fortis Healthcare Limited	2.7
	Glenmark Pharmaceuticals	2.3
	Alkem Laboratories Limited	2.1
	Cadila Healthcare	1.9
	Mankind Pharma Limited	1.9
	IPCA Laboratories Limited	1.8
	Biocon	1.7
	Gland Pharma Limited	1.5
	Krishna Institute of Medical Science Ltd	1.3
	Abbott India Limited	0.91

Sun Pharmaceutical Ind Ltd
Divi s Laboratories Limited

Market value of each ticked company in Aditya Birla Sun Life Nifty Healthcare ETF, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Divi s Laboratories Limited
Sept 2025	₹6.4 Cr	₹2.8 Cr
Oct 2025	₹6.9 Cr	₹3.3 Cr
Nov 2025	₹9 Cr	₹3.8 Cr
Dec 2025	₹9.4 Cr	₹4.2 Cr
Jan 2026	₹9 Cr	₹4.1 Cr
Feb 2026	₹12.2 Cr	₹5.4 Cr
Mar 2026	₹14.2 Cr	₹5.8 Cr
Apr 2026	₹14.2 Cr	₹6.1 Cr
May 2026	₹14.1 Cr	₹6.3 Cr
Jun 2026	₹14.8 Cr	₹6.3 Cr
Jul 2026	₹15 Cr	₹7.3 Cr
Aug 2026	₹15.1 Cr	₹8.6 Cr
Sept 2026	₹12.7 Cr	₹7.8 Cr

Fig. 1.Market value of each ticked company in Aditya Birla Sun Life Nifty Healthcare ETF, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	5	47.87

Mid Cap	13	48.31

Small Cap	2	3.80

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	69.9K	12.7	17.00
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	8.41K	7.8	10.46
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	6.82K	5.6	7.45
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	25.7K	5.1	6.81
Cipla	Equity	Pharmaceuticals & Biotechnology	37.1K	5	6.69
Dr Reddy s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	40.2K	5	6.64
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	9.74K	4.7	6.26
Max Healthcare Institute Limited	Equity	Healthcare Services	49.1K	4.6	6.11
Lupin	Equity	Pharmaceuticals & Biotechnology	16K	3.3	4.35
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	18.2K	3.1	4.08
Fortis Healthcare Limited	Equity	Healthcare Services	34.4K	2.7	3.54
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	9.91K	2.3	3.10
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	4.01K	2.1	2.77
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	16.3K	1.9	2.54
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	7.45K	1.9	2.50
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	9.15K	1.8	2.36
Biocon	Equity	Pharmaceuticals & Biotechnology	46K	1.7	2.28
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	5.25K	1.5	2.04
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	17.6K	1.3	1.76
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	337	0.91	1.22

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.